Patents Taking A Leading Role In War Against High Drug Prices

There's been more and more scrutiny over how pharma companies use patents to find loopholes in anti-competition laws. Now Sen. John Cornyn (R-Texas) is going after a practice where companies make minor formula adjustments to prevent generic substitutions. In other pharmaceutical news: more kickback settlements, pharma-funded charities, first-quarter profits, copays and more.

from Kaiser Health News http://bit.ly/2vmYTR1